Effect of the Duration of Pre-oxygenation on Apnea Tolerance in Obese Patients During the Induction of General Anesthesia
NCT04699435 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2023-04-14
Summary
The occurrence of arterial oxygen desaturation (hypoxemia) during the induction of general anesthesia remains one of the main causes of complications and mortality in anesthesia. In a healthy patient breathing in ambient air \[Inspired O2 fraction (FiO2) = 21%\] before the onset of narcosis, a drop in arterial O2 saturation (SpO2) occurs within 1 to 2 minutes. When pre-oxygenation is performed for 3 minutes in healthy subjects with FiO2 = 100%, SpO2 is less than 97% after 7.9 minutes of apnea and arterial O2 desaturation (SpO2 \<93%) occurs after 8 to 9 minutes. For this reason and "in order to prevent arterial desaturation during tracheal intubation or supraglottic device insertion maneuvers", it is recommended "to systematically perform a pre-oxygenation procedure (3 min / 8 deep breaths) , including in the context of an emergency ". Tolerance to apnea is conditioned by the amount of O2 stored during the pre-oxygenation phase. Oxygen is transported to different tissues in 2 forms: combined with hemoglobin (Hb) and in dissolved form. In ambient air, the quantity of O2 transported by the Hb is much greater than the part transported in dissolved form. However, when the patient breathes a gas enriched in O2, all the molecules of Hb are quickly saturated (SpO2 = 100%), while the content of dissolved O2 increases constituting a reserve allowing to increase the tolerance to apnea.
Under usual conditions (3 minutes pre-oxygenation with FiO2 = 1), tolerance to apnea is shorter in obese subjects. Arterial O2 desaturation occurs after 2-3 minutes of apnea in patients with grade III obesity \[Body Mass Index (BMI)\> 35 kg / m2\]. In addition, arterial O2 desaturation is faster the higher the BMI is. In fact, in obese patients, the lung volumes that can be mobilized in the supine position are modified compared to the non-obese subject: decrease in vital capacity, decrease in expiratory reserve volume, increase in airway resistance, decrease in thoracic compliance. These changes are, in part, explained by the weight of tissue on the rib cage and abdomen leading to compression of the lungs and diaphragm. In addition, there is also an increase in oxygen consumption in patients with a BMI\> 40.
Different techniques have been proposed to increase apnea tolerance in obese patients. For Dixon et al., The desaturation of the morbidly obese subject (BMI\> 40 kg / m2) is less rapid after 3 minutes of pre-oxygenation carried out with the patient in a half-seated position at 25 °: 201 seconds against 155 seconds in the Control group. This additional time seems to correlate with the value of the arterial pressure in O2 (PaO2) measured at the end of the pre-oxygenation (442 vs 360 mmHg). Likewise, the proclive position (30 ° reverse Trendelenburg) during the pre-oxygenation phase seems effective in limiting the occurrence of desaturation after induction.
The O2 reserve is usually assessed by measuring the partial pressure of O2 in the arterial blood. A value greater than 100 mmHg indicates that an amount of O2 is "in reserve", increasing tolerance to apnea. In practice, this examination is not feasible in current practice because it requires the performance of an invasive procedure, cannot be measured continuously and the rendering of the result is delayed by several minutes. In recent years, a technology based on spectrophotometry has been developed to measure the saturation of Hb in O2 in non-pulsatile blood. By algorithmic transformation, an Oxygen Reserve Index (ORI) is calculated. Its value varies from 0 to 1 and covers a data range between 100 and 200 mmHg of blood pressure in O2 (moderate hyperoxia). This data is obtained continuously and non-invasively from a sensor (RD Rainbow SET R Sensors; Masimo) placed on the 3rd or 4th finger of the hand. When a patient receives an O2 enriched gas mixture, the value of ORI increases rapidly and reaches a plateau. When the patient is in apnea, the drop in the ORI value precedes the drop in SpO2 by several tens of seconds. In a pilot study observing the kinetics of ORI in non-obese (BMI \<25 kg / m2) or obese (BMI\> 30 kg / m2) anesthetized patients, we observed that the time required to reach the plateau of l The ORI was longer (133 ± 30 seconds) in "obese" patients compared to "non-obese" patients (89 ± 28 seconds). Thus, one hypothesis to explain the poorer tolerance to apnea in obese patients would be that the duration of 3 minutes of pre-oxygenation as recommended in the recommendations is insufficient.
Conditions
- Anesthesia
Interventions
- OTHER
-
Control
All patients are installed with a 30 ° proclive and have pre-oxygenation (FiO2 = 1) with a face mask. At the end of the 3-minute pre-oxygenation for the "Control" group, the values of ORI, SpO2, mean arterial pressure and heart rate are recorded.
- OTHER
-
PreOx_3min
Patients with a BMI between 30 kg / m² and 40 kg / m² are distributed according to a random allocation in the group "PreOx\_3min". All patients are installed with a 30 ° proclive and have pre-oxygenation (FiO2 = 1) with a face mask. At the end of the 3-minute pre-oxygenation for the "PreOx\_3min" group, the values of ORI, SpO2, mean arterial pressure and heart rate are recorded.
- OTHER
-
PreOx_6min
Patients with a BMI between 30 kg / m² and 40 kg / m² are distributed according to a random allocation in the group "PreOx\_6min". All patients are installed with a 30 ° proclive and have pre-oxygenation (FiO2 = 1) with a face mask. At the end of the 6-minute pre-oxygenation for the "PreOx\_3min" group, the values of ORI, SpO2, mean arterial pressure and heart rate are recorded.
Sponsors & Collaborators
-
Fondation Hôpital Saint-Joseph
lead OTHER
Principal Investigators
-
Pascal ALFONSI, MD · Fondation Hôpital Saint-Joseph
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-13
- Primary Completion
- 2024-02-27
- Completion
- 2024-12-30
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Effectiveness of the Administration of Local Anesthetics Via Two Catheters Placed During Surgery, and Study of the Benefits on Respiratory Function and Therefore on Recovery Time
NCT06463899 ·Status: RECRUITING ·Phase: NA
-
Intraoperative Hyperoxia and MINS
NCT04540276 ·Status: UNKNOWN
-
The Effect of Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
NCT06862245 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Changes After Anesthesia With Propofol: Study of Biomarkers
NCT02442232 ·Status: COMPLETED
-
Hypnosis Before the Induction of Anesthesia
NCT02249364 ·Status: COMPLETED ·Phase: NA
-
Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol
NCT01531491 ·Status: COMPLETED ·Phase: NA
-
Modification of Blood Pressure Levels and Oxygen Saturation in Patients Undergoing Conscious Sedation
NCT03789942 ·Status: COMPLETED ·Phase: NA
-
Oxygen Extraction and Delivery in Elderly During Major Surgery
NCT03355118 ·Status: COMPLETED
-
The Hypotensive Effect of Propofol: an Observational Study
NCT01508351 ·Status: COMPLETED
-
Breath Monitoring of Propofol (Observational Study)
NCT01892683 ·Status: COMPLETED
-
Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
NCT06862349 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Intravenous Anesthetics and Inhaled Anesthetics on Patients' Postoperative Sleep
NCT04123249 ·Status: COMPLETED ·Phase: NA
-
Analyzing the Relationship Between Speed Propofol is Given and Low Blood Pressure
NCT05415436 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide
NCT02149628 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Anesthesia With Propofol Versus Desflurane in Obese Patients
NCT03417518 ·Status: COMPLETED ·Phase: PHASE4
-
Improved Patient Recovery After Anesthesia
NCT01477398 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Different Propofol Formulations
NCT01041872 ·Status: COMPLETED ·Phase: PHASE4
-
Depth of Anaesthesia and Long-term Survival: The Balanced Anaesthesia Follow-up Study
NCT04965324 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Opioids on Heart Rate During Rapid Sequence Intubation
NCT05384665 ·Status: TERMINATED ·Phase: NA
-
Comparison of Total Intravenous Anesthesia and Inhalational Anesthesia in Opioid-Free Anesthesia for Bariatric Surgery: A Randomized Controlled Trial
NCT06390046 ·Status: COMPLETED ·Phase: NA
-
Anaesthesia With Propofol Versus Midazolam : Effect on Oxidative Stress in the Brain of Head Trauma Patients
NCT00336882 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of Pre-anesthetic Evaluation on the Anxiety
NCT07032012 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Nitrous Oxide on Intravenous Closed-loop Anesthesia
NCT00547209 ·Status: COMPLETED ·Phase: PHASE4
-
Observation on Administration of Propofol at Different Titration Endpoints
NCT06685198 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
VitamIn and oXygen Interventions and Cardiovascular Events
NCT03494387 ·Status: COMPLETED ·Phase: PHASE4